Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and TobagoF R Cleghorn, N Jack, J K Carr, et al.
Prostate Cancer and Prostatic Diseases|March 16, 2022
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancerLandon C Brown, Susan Halabi, Jason A Somarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2017
Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus IpilimumabJohn S Yi, Neal Ready, Patrick Healy, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Journal of Virology|April 20, 2012
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationStephanie A Freel, Ralph A Picking, Guido Ferrari, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 13, 2024
Transport of dust across the Solar System: Constraints on the spatial origin of individual micrometeorites from cosmic-ray exposureJ Feige, A Airo, D Berger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infectionMichael R Betts, Barbara Exley, David A Price, et al.
Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.
Pageof 16